|
Volumn 206, Issue 6, 2008, Pages 1193-1203
|
Correction (DOI:10.1016/j.jamcollsurg.2007.12.026);Breast Cancer in Young Women
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EXEMESTANE;
FLUOROURACIL;
ISOSULFAN BLUE;
LETROZOLE;
METHOTREXATE;
RALOXIFENE;
TAMOXIFEN;
TECHNETIUM SULFUR COLLOID TC 99M;
AMENORRHEA;
BREAST CANCER;
BREAST SURGERY;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER LOCALIZATION;
CANCER MORTALITY;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RISK;
CANCER SCREENING;
CAUSE OF DEATH;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
ENDOCRINE SYSTEM;
ENDOMETRIUM CANCER;
ENVIRONMENTAL EXPOSURE;
FAMILY HISTORY;
FEMALE FERTILITY;
GENETIC PREDISPOSITION;
HODGKIN DISEASE;
HUMAN;
MAMMOGRAPHY;
MENOPAUSE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVARY INSUFFICIENCY;
POSITRON EMISSION TOMOGRAPHY;
PREGNANCY;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RACE DIFFERENCE;
REPRODUCTION;
REVIEW;
RISK ASSESSMENT;
RISK REDUCTION;
SCINTIMAMMOGRAPHY;
THROMBOEMBOLISM;
TREATMENT RESPONSE;
|
EID: 43849094996
PISSN: 10727515
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jamcollsurg.2008.06.329 Document Type: Erratum |
Times cited : (71)
|
References (114)
|